Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Volumn 12, Issue 14 Pt 1, 2006, Pages 4265-4273

  Robertson, Michael J ^a   Mier, James W ^a   Logan, Theodore ^a   Atkins, Michael ^a   Koon, Henry ^a   Koch, Kevin M ^a   Kathman, Steven ^a   Pandite, Lini N ^a   Oei, Coreen ^a   Kirby, Lyndon C ^a   Jewell, Roxanne C ^a   Bell, William N ^a   Thurmond, Linda M ^a   Weisenbach, Jill ^a   Roberts, Suzanne ^a   Dar, Mohammed M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 18; RECOMBINANT PROTEIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DOSE RESPONSE; FEMALE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; MALE; MELANOMA; METABOLISM; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, RENAL CELL; COHORT STUDIES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HODGKIN DISEASE; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-18; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 33847352726     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0121     Document Type: Article

References (0)